High -quality development and synthetic biology seminar on biomedicine is held in Nanjing

At present, the wave of biotechnology revolution has swept the world and accelerates integration into economic and social development, providing a new solution for human beings to respond to major challenges such as life health, climate change, resource energy safety, and food security. The biomedical industry is a strategic high -tech industry that is related to the national economy and people's livelihood. As an important part of its synthetic biology, it is known as the "Third Biotechnology Revolution". It is a "golden key" in the high -end biological industry in the future. The cutting -edge discipline of original breakthrough and interdisciplinary cross -fusion. How to open this "golden key"? On September 16th, Gaotu Yida Research Institute organized a special meeting in Nanjing to discuss the high -quality development of the biomedical industry.

The meeting invited the Deputy Director of the Jiangsu Provincial Department of Science and Technology and a member of the party group to overcome Li Ping, Li Xiubin, deputy director of the Jiangsu State -owned Assets Supervision and Administration Commission and member of the Party Committee, Liu Wei, Director of the Enterprise Development and Reform Division of the Jiangsu Provincial SASAC, the Institute of Microbiology of the Chinese Academy of Sciences, and the National Key Laboratory Wu Bian, deputy director, Guo Henghua, chairman and general manager of Anhui Huarheng Biotechnology Co., Ltd., Wang Yong, deputy director of the Key Laboratory of the Chinese Academy of Sciences, attended the meeting.

The meeting was chaired by Cui Zhaofei, deputy general manager of Gaotou Group, Wang Huiqing, Secretary of the Party Committee of Gaotou Group and Chairman of Gao Investment Yida Research Institute. Cheng Xiaoguang, Zhang Xiaohong, deputy general manager of Gaotou Group, chairman and founding partner of Yida Capital, Ying Wenlu, deputy dean of Gaotu Yida Research Institute, Xue, the founding partner of Yida Capital Shi Yunzhong, Yida Capital Senior Partner Xue Yi and relevant departments attended the meeting.

Wang Huiqing, Secretary of the Party Committee and Chairman of the Gaotou Group, and the Dean of Gao Investment Yida Research Institute, pointed out in his speech that the special seminar of high -quality and synthetic biology of Jiangsu Province held this time was the industry of Gaotu Yida Research Institute. The attempts with industry research are also a pragmatic measure to further promote the high -quality development of the biomedical industry in our province. In the next step, Gaotou Group and Yida Capital will further do a real and operate high -Investment Yida Research Institute, take over policies, Xialian Industry, and gather resources from all parties. Provincial strategic emerging industry strong chain replenishment chain, contributing high investment for Jiangsu scientific and technological innovation and high -level technology self -reliance.

The deputy director of the Jiangsu Provincial Department of Science and Technology, Zi Leping, delivered a speech and introduced the development status of the biomedical industry in Jiangsu Province. He said that the biopharmaceutical industry in Jiangsu Province has a good development foundation, and its scale quality and efficiency are at the forefront of the country. In 2021, the scale of the biomedical industry in the province continued to lead the country, an increase of 10.3%year -on -year, and the total scale accounted for 1/8 of the country. The number of new drug registrations ranks among the forefront of the country. In 2021, there were 11 innovative medicines in Jiangsu Province, and 7 innovative medical equipment was approved to be listed and ranked first in the country. From the perspective of enterprise competition, 12 companies have entered the top 100 Chinese pharmaceutical industry, accounting for 1/8 of the country. The listed enterprises in Jiangsu Province exceeded 700,000, and the development benefits of industrial agglomeration were obvious. It is hoped that high -investment and Yida in the future can further give full play to the comprehensive advantages of private equity and entrepreneurial investment in equity financing and value -added services, and promote the high -quality development of the biomedicine industry in Jiangsu Province to the top.

How to promote the creation of first -class enterprises means that what does it means to Jiangsu state -owned enterprises and Jiangsu state -owned assets, this is also a major issue that the SASAC will consider recently. Li Xiubin, deputy director of the Jiangsu Provincial SASAC, pointed out in his speech that the Provincial State -owned Assets Supervision and Administration Commission supports the development of the Gao Investment Yida Research Institute, conducts in -depth thinking around major national supervision issues, and looks forward to supporting enterprises' long -term development. Looking forward to the research of Gaotou Group and Yida Capital in the field of biomedicine and synthetic biology to achieve better and in -depth results, invest better and more returns, and make due to the development of the Jiangsu industrial chain. contribute.

Ying Wenlu, chairman of Yida Capital and Deputy Dean of Gao Investment Yida Research Institute, insists on investing and research, investing along the industrial chain and industrial tree, and is a corporate culture that deeply penetrates the bone marrow of Yida. From macro -policy research to the industrial research of the middle view, and to micro -enterprise research, every investment manager of Yida is an analyst of the industry's industry. Taking the investment research of the biomedical industry as an example, Yida Capital has established a special large health team since its establishment in 2014, trained a number of professional talents, set up a series of theme funds of the Health Medical Series and achieved excellent results. We hope to build Gaotu Yida Research Institute into a platform for adsorption and empowerment, adsorb top resources, and provide resource capacity for the investment enterprises, partners of ecosystems, and high -quality development of the industry.

The theme sharing session, Wu Bian, a winner of the National Outstanding Youth Science Fund, a researcher at the Institute of Microbiology of the Chinese Academy of Sciences, and the deputy director of the National Key Laboratory, shared the theme of "Synthetic Biology -From Mathematics to Buildings". He pointed out that the world's mainstream economies have clearly planned synthetic biology. my country's "Fourteenth Five -Year Plan" and the 2035 visual goal planning planning synthetic biology is listed as the technology forefront of science and technology. He said that synthetic biotechnology and products have begun to profoundly affect the global economy and people’s lifestyle, and gradually penetrate into all walks of life. In medical, food, energy, chemical industry, etc. The industries upgraded and transformed to high -end industries, and the prospects were very broad.

Persist in doing difficult and correct things, Guo Henghua, chairman and general manager of Anhui Huarheng Biotechnology Co., Ltd. shared the entrepreneurial process of Huaheng Biological, and analyzed the status quo of the synthetic biology industry from the perspective of entrepreneurs. She believes that synthetic biology is a future -oriented industry, not only an important technological force to promote China's biological economic development, but also an important underlying support to achieve the strategic goals of "carbon peaks" and "carbon neutralization". However, the booming development of the new industry requires linking policies, capital, and resources. It is hoped that the elements of all parties will be more tolerant and support for the industrialization of original technology and original results. Wang Yong, deputy director of the Key Laboratory of the Chinese Academy of Sciences, conducted the theme of "Synthetic Biology and Biomedical Industry". He introduced the discovery and manufacturing process of natural product discovery and manufacturing of synthetic biology, strategic layout of major countries in the world, and my country's synthetic biology biology Scientific and technological progress, platform construction and typical enterprises. He believes that the formation of regional innovation clusters that promote the promotion of synthetic biology, and the potential impact of synthetic biotechnology is not only in the field of health, but also includes new tasks, accelerating the marketization of products, improving agriculture, ecology, and economics. And all aspects of energy products.

Xue Yi, a senior partner of Yida Capital, shared the theme of "The Shallow Observation of Technology Innovation to Industrial Revolutionary Combination Biology". He believes that the driver factor supporting the development of synthetic biology includes technology -driven, policy -driven and demand -driven. As a large manufacturing province, Jiangsu should have the responsibility of industrial leadership and the strengthening of the industrial chain in this field. From the perspective of the investor's perspective, he puts forward the problems of the current selection ideas of the industry, the long product research and development cycle, and the protection of intellectual property rights. Policy suggestions, biological safety and databases, industrial upgrading and industrial creation.

At the seminar site, the speaker, entrepreneurs, investors, and researchers at Gao Investment Yida Research Institute are currently encountered by the development of the synthetic biology development? Are there any overseas experiences that can be used for reference? How to view gene editing, manual artificially New technical methods such as intelligent and other technical means have in -depth exchanges such as the role of the supply chain and technology of the stuck neck in the development of the synthetic biology?

At the meeting site, the appointment ceremony of the experts of Gaotu Yida Research Institute was also held.

- END -